Hinge Health (NYSE: HNGE) reported second-quarter 2026 revenue of $213 million, marking a 53% increase from the previous year and exceeding its guidance of $200 million to $202 million. The company also raised its full-year revenue outlook to $856 million to $860 million, representing an expected 46% growth at the midpoint. For the quarter, Hinge Health’s income from operations was $62 million, more than double the previous year’s figures.
Hinge Health’s calculated billings reached $862 million, a 52% increase year-over-year, signaling strong future revenue potential. Additionally, the company is set to acquire Cylinder Health for $105 million, aimed at enhancing its offerings in gastrointestinal care, with projections for Cylinder to generate $7 million to $8 million in revenue in the remaining months of 2026.
Looking ahead, Hinge Health expects third-quarter revenue between $223 million and $225 million, signifying a 45% year-over-year growth at the midpoint. The company ended the quarter with cash and equivalents of $476 million, positioning it well for future investments and operational initiatives.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
